Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 30, 2005
Olanzapine-induced suppression of cocaine self-administration in rhesus monkeysLeonard L Howell, Kristin M Wilcox, Kimberly P Lindsey, et al.
Pharmacology, Biochemistry, and Behavior|January 30, 2007
Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeysHeather L Kimmel, Joann A O'Connor, F Ivy Carroll, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 18, 2016
Effects of a Serotonin 2C Agonist and a 2A Antagonist on Actigraphy-Based Sleep Parameters Disrupted by Methamphetamine Self-Administration in Rhesus MonkeysMaylen Perez Diaz, Monica L Andersen, Kenner C Rice, et al.
Pharmacology|January 16, 2009
Effects of histamine H(3) receptor activation on the behavioral-stimulant effects of methamphetamine and cocaine in mice and squirrel monkeysMatthew L Banks, Daniel F Manvich, Rayna M Bauzo, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 12, 2012
The serotonin 2C receptor antagonist SB 242084 exhibits abuse-related effects typical of stimulants in squirrel monkeysDaniel F Manvich, Heather L Kimmel, Debra A Cooper, et al.
Psychopharmacology|July 17, 2019
Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male miceAboagyewaah Oppong-Damoah, Kristen E Curry, Bruce E Blough, et al.
International Journal of Pharmaceutics|August 21, 2018
Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patchSindhu S Ganti, Sonalika A Bhattaccharjee, Kevin S Murnane, et al.
Drug and Alcohol Dependence|November 24, 2018
Effects of acute treatments with the serotonin 2A antagonist M100907 alone or in combination with the serotonin 2C agonist WAY163909 on methamphetamine self-administration in rhesus monkeysMelis Odabas-Geldiay, Hannah Shields, Lais F Berro, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|March 6, 2025
Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic IndustryJacob S Aday, Brian S Barnett, Dan Grossman, et al.
Psychopharmacology|December 18, 2017
(±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMAElizabeth G Pitts, Daniel W Curry, Karly N Hampshire, et al.
Pageof 15